{"title": "Covid 19 vaccine safety and efficacy", "author": "Misbah Biabani Follow", "url": "https://www.slideshare.net/misbahbiabani/covid-19-vaccine-safety-and-efficacy", "hostname": "slideshare.net", "description": "ADD A FOOTER 1 2 LIPID NANOPARTICLES COVID-19 SPIKE PROTEIN In 2018, the FDA approved the first-ever RNA interference therapeutic product marketed as Onpattr...", "sitename": "SlideShare", "date": "2020-11-08", "cleaned_text": "LIPID NANOPARTICLES COVID-19 SPIKE PROTEIN In 2018, the FDA approved the first-ever RNA interference therapeutic product marketed as Onpattro\u00ae, a lipid nanoparticle (LNP)-based formulation of siRNA for the treatment of hereditary transthyretin (TTR) amyloidosis. 3 Covid-19 vaccine approval process WWW.FDA.GOV/CBER WWW.CDC.GOV Vaccines and Related Biological Products Advisory Committee (VRBPAC) 4 ADD A FOOTER 5 Operation warp speed (OWS) is US government and private Partnership program to facilitate and accelerate the development, Manufacturing, and distribution of Covid-19 vaccine, therapeutics and diagnostics. Vaccines and Related Biological Products Advisory Committee (VRBPAC). This group consist of industry outside experts and independent of federal government. Phase 1 Trials 20-100 Healthy volunteers. Any serious side effects. Dose size related to side effects. . 6 FDA licenses vaccines only if its safe and effective Phase 2 Trials Several hundred volunteers. Most common short term side effects. How immune system responding to vaccine. Hundreds or thousands of volunteers. Compared placebo and vaccine. How safe & effective. Phase 3 Trials ADD A FOOTER 7 Phase 3 trials are decisive phase which includes results of double blind randomized clinical trails. Vaccines are made in batches called lots. Manufacturer must test all lots to make sure they are safe and pure. FDA inspects manufacturing sites regularly to ensure GMP followed. ADD A FOOTER 8 Phase III Trial data Pfizer/BioNTech Moderna Primary endpoint Symptomatic COVID N= 30,418 Age >12-year-old 94.5% blind RCT Double blind RCT Intervention 2 dose vaccine vs placebo (1:1) 2 dose vaccine vs placebo (1:1) Exclusion criteria Previous symptomatic COVID. Pregnancy/breast feeding Significant immunosuppression Use of medications to prevent COVID. "}